LL

January 21, 2020
Published by LL at January 21, 2020
Categories

OBI Pharma Granted U.S. FDA Orphan Drug Designation for the Treatment of Gastric Cancer for Its Antibody-Drug Conjugate (ADC) Targeted Cancer Therapy, OBI-999

[…]
Do you like it?0
Read more
January 9, 2020
Published by LL at January 9, 2020
Categories

OBI Pharma, Inc. to Present at the J.P. Morgan Healthcare Conference

[…]
Do you like it?0
Read more
December 26, 2019
Published by LL at December 26, 2019
Categories

OBI Pharma Granted FDA Orphan Drug Designation for the Treatment of Pancreatic Cancer for Its Antibody-Drug Conjugate (ADC) Targeted Cancer Therapy, OBI-999

[…]
Do you like it?0
Read more
December 19, 2019
Published by LL at December 19, 2019
Categories

OBI Pharma Announces Initiation of a Phase 1/2 Study of Its Antibody-Drug Conjugate (ADC) Targeted Cancer Therapy, OBI-999.

[…]
Do you like it?0
Read more
123456
Next page